MA (EU) Number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/18/1308/001 
EU/1/18/1308/002 
EU/1/18/1308/003 
Vyxeos 
liposomal  
Vyxeos 
liposomal  
Vyxeos 
liposomal  
2.2  
mg/ml / 5 
mg/ml 
2.2  
mg/ml / 5 
mg/ml 
2.2  
mg/ml / 5 
mg/ml 
Powder for 
concentrate for 
solution for 
infusion 
Powder for 
concentrate for 
solution for 
infusion 
Powder for 
concentrate for 
solution for 
infusion 
Intravenous use 
vial (glass) 
44 mg;100 mg 
1 vial  
Intravenous use 
vial (glass) 
44 mg;100 mg 
2 vials  
Intravenous use 
vial (glass) 
44 mg;100 mg 
5 vials  
1/1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
